Optimized Residual dsRNA Detection for mRNA Therapeutics
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
DoE for Clone Selection and Process Development to Meet Biosimilar Critical Qualities Attributes and High Productivity
The Evolving Role of Remote Monitoring
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Sailing into the Trade Winds
Assembling the Crew
Discussing the Advancements in Oncology
Designing A Recipe for Stem Cell Therapy Success
The Power of Aqueous Detergents in Critical Cleaning
Preparing the Yacht for the Race
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Disaster Strikes
Transforming Market Insights into Growth
Growing as a Trusted, Dedicated Commercial Biologics CDMO
Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Rethinking the Conventional CDMO Model
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Assessing Developability and Designing Advanceable Formulations from the Start
Why Life Science Companies Surged amid a Global M&A Downturn
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Plan Ahead: Mastering Your AI Budget for 2025 Success
Optimized Residual dsRNA Detection for mRNA Therapeutics
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors